CWA Asset Management Group’s TriSalus Life Sciences TLSI Stock Holding History

CWA Asset Management Group’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$310K	Hold	72,000	–	–	0.01%	591
2026 Q2	$328K	Hold	72,000	–	–	0.01%	571
2026 Q1	$288K	Hold	72,000	–	–	0.01%	570
2025 Q4	$503K	Hold	72,000	–	–	0.02%	456
2025 Q3	$335K	Buy	+72,000	New	+$337K	0.01%	538

Other funds holding TLSI

Thompson Siegel & Walmsley Richmond, Virginia $5.37B AUM 3.99% 1-Year Est. Return

Perkins Capital Management Wayzata, Minnesota $140M AUM 109.55% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Connecticut Wealth Management Farmington, Connecticut $2.73B AUM 14.39% 1-Year Est. Return

Provenance Wealth Advisors Fort Lauderdale, Florida $1.69B AUM 11.53% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

HRC

Hoertkorn Richard Charles $146M AUM 60.49% 1-Year Est. Return

EverSource Wealth Advisors Birmingham, Alabama $3.11B AUM 21.48% 1-Year Est. Return

CWA Asset Management Group's TLSI Position: Q3 2026 in Review

CWA Asset Management Group held its TriSalus Life Sciences (TLSI) position steady in Q3 2026 at 72,000 shares worth $310K. The position accounts for 0.01% of the portfolio, ranked #591.

CWA Asset Management Group first reported a position in TLSI in Q3 2025 and has held it in 5 quarters since. The position peaked at $503K in Q4 2025. 22 funds tracked by Wall St. Rank hold TLSI as of Q3 2026.

CWA Asset Management Group held 72,000 shares of TriSalus Life Sciences worth $310K as of Q3 2026.
CWA Asset Management Group left its TriSalus Life Sciences share count unchanged in Q3 2026.
TriSalus Life Sciences made up 0.01% of CWA Asset Management Group's portfolio in Q3 2026, its #591 holding.
CWA Asset Management Group first reported a position in TriSalus Life Sciences in Q3 2025 and has held it in 5 quarters since.
CWA Asset Management Group's TriSalus Life Sciences position peaked at $503K in Q4 2025.
22 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q3 2026.

Based on CWA Asset Management Group's 13F filing for Q3 2026, filed 19 Oct 2026.